B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nad

300 PubMed studies analyzed · 1 RCTs · Evidence Score: 43.8

Research Domains

Nad has been studied across 18 research domains including ⏳ Longevity & Aging, ⚡ Energy & Fatigue, 🔬 Oncology, 🔬 Inflammation, 🔥 Metabolic. The primary research focus is ⏳ Longevity & Aging with 40% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nad is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.